Related Experiment Video
Updated: Aug 14, 2026
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
[Future possibilities of the multiple sclerosis treatment]
E Havrdová1, D Horáková, I Kovárová
1Neurologická klinika 1, LF UK a VFN, Praha. ehavr@lf1.cuni.cz
Casopis Lekaru Ceskych
|November 11, 2005
Summary
Multiple sclerosis (MS) is an autoimmune central nervous system disease causing nerve damage. Early treatment targeting inflammation is crucial to slow irreversible disability progression in MS patients.
Area of Science:
- Neuroimmunology
- Autoimmune disorders of the central nervous system
Context:
- Multiple sclerosis (MS) involves central nervous system inflammation and neurodegeneration.
- Myelin sheath destruction and nerve fiber loss characterize MS pathology.
- Current treatments primarily manage inflammation, with early intervention critical for delaying disability.
Purpose:
- To review current and emerging therapeutic strategies for multiple sclerosis.
- To highlight the limitations of existing treatments and the need for advanced therapies.
Summary:
- High-dose corticosteroids are standard for MS attacks.
- Disease-modifying drugs like interferon beta and glatiramer acetate offer modest benefits.
- Advanced treatments include immunosuppressives, intravenous immunoglobulins, immunoablation, and stem cell transplantation.
- Natalizumab showed promise but was halted due to adverse effects.
- Ongoing research explores novel monoclonal antibodies, cytostatics, and DNA vaccination for inducing tolerance.
Impact:
- Emphasizes the importance of early and intensified treatment in managing MS.
- Underscores the ongoing search for more effective and safer MS therapies.
- Highlights DNA vaccination as a potential future strategy for inducing immune tolerance in MS.
